Molecular Mechanisms of HIV-1 Vertical Transmission and Pathogenesis in Infants

Advances in Pharmacology

Volumn 56, Issue , 2008, Pages 453-508

  Ahmad, Nafees ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

CHILD; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; NEWBORN; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PRESCHOOL CHILD; REVIEW;

CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; RECEPTORS, CHEMOKINE;

EID: 37249038549     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(07)56015-1     Document Type: Review

References (261)

1. Abrams E.J., Weedon J., Steketee R.W., Lambert G., Bamji M., Brown T., Kalish M.L., Schoenbaum E.E., Thomas P.A., and Thea D.M. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J. Infect. Dis. 178 (1998) 101-108
2. Adjorlolo-Johnson G., De Cock K.M., Ekpini E., Vetter K.M., Sibailly T., Brattegaard K., Yavo D., Doorly R., Whitaker J.P., Kestens L., Ou C.-Y., George J.R., et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 272 (1994) 462-466
3. Ahmad N. Maternal-fetal transmission of human immunodeficiency virus. J. Biomed. Sci. 3 (1996) 238-250
4. Ahmad N. Molecular mechanisms of human immunodeficiency virus type 1 mother-infant transmission. Adv. Pharmacol. 49 (2000) 387-416
5. Ahmad N. The vertical transmission of human immunodeficiency virus type 1: Molecular and biological properties of the virus. Crit. Rev. Clin. Lab. Sci. 42 (2005) 1-34
6. Ahmad N., and Venkatesan S. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241 (1989) 1481-1485
7. Ahmad N., Baroudy B.M., Baker R.C., and Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J. Virol. 69 (1995) 1001-1012
8. Ahmad N., Matala E., Yedavalli R.K.V., Hahn T., and Husain M. Chacterization of human immunodeficiency virus type-1 involved in maternal-fetal transmission. In: Jameel S., and Villarreal L. (Eds). "Advances in Animal Virology" (2000), Oxford & IBH Publishing Co. Pvt. Ltd., New Delhi 351-370
9. Akari H., Arold S., Fukumori T., Okazaki T., Strebel K., and Adachi A. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74 (2000) 2907-2912
10. Aldrovandi G.M., Gao L., Bristol G., and Zack J.A. Regions of human immunodeficiency virus type 1 nef required for function in vivo. J. Virol. 72 (1998) 7032-7039
11. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., and Berger E.A. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 (1996) 1955-1958
12. Amadori A., de Rossi A., Giaquinto C., Faulkner-Valle G., Zacchello F., and Chieco-Bianchi L. In-vitro production of HIV-specific antibody in children at risk of AIDS. Lancet 1 (1988) 852-854
13. Amedee A.M., Lacour N., Gierman J.L., Martin L.N., Clements J.E., Bohm Jr. R., Harrison R.M., and Murphey-Corb M. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J. Virol. 69 (1995) 7982-7990
14. Auger I., Thomas P., De Gruttola V., Morse D., Moore D., Williams R., Truman B., and Lawrence C.E. Incubation periods for paediatric AIDS patients. Nature 336 (1988) 575-577
15. Balotta C., Vigano A., Riva C., Colombo M.C., Salvaggio A., de Pasquale M.P., Crupi L., Papagno L., Galli M., Moroni M., and Principi N. HIV type 1 phenotype correlates with the stage of infection in vertically infected children. AIDS Res. Hum. Retroviruses 12 (1996) 1247-1253
16. Bamji M., Thea D.M., Weedon J., Krasinski K., Matheson P.B., Thomas P., Lambert G., Abrams E.J., Steketee R., and Heagarty M. Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group. Pediatr. Infect. Dis. J. 15 (1996) 891-898
17. Battiste J.L., Mao H., Rao N.S., Tan R., Muhandiram D.R., Kay L.E., Frankel A.D., and Williamson J.R. Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex. Science 273 (1996) 1547-1551
18. Baur A.S., Sass G., Laffert B., Willbold D., Cheng-Mayer C., and Peterlin B.M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6 (1997) 283-291
19. Bawdon R.E., Gravell M., Hamilton R., Sever J., Miller R., and Gibbs C.J. Studies on the placental transfer of cell-free human immunodeficiency virus and p24 antigen in an ex vivo human placental model. J. Soc. Gynecol. Investig. 1 (1994) 45-48
20. Becquart P., Hocini H., Levy M., Sepou A., Kazatchkine M.D., and Belec L. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J. Infect. Dis. 181 (2000) 532-539
21. Blanche S., Rouzioux C., Moscato M.L., Veber F., Mayaux M.J., Jacomet C., Tricoire J., Deville A., Vial M., Firtion G., et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N. Engl. J. Med. 320 (1989) 1643-1648
22. Bobbitt K.R., Addo M.M., Altfeld M., Filzen T., Onafuwa A.A., Walker B.D., and Collins K.L. Rev activity determines sensitivity of HIV-1-infected primary T cells to CTL killing. Immunity 18 (2003) 289-299
23. Bour S., Schubert U., and Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: Implications for the mechanism of degradation. J. Virol. 69 (1995) 1510-1520
24. Bryson Y.J., Luzuriaga K., Sullivan J.L., and Wara D.W. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N. Engl. J. Med. 327 (1992) 1246-1247
25. Bulterys M., Chao A., Dushimimana A., Kageruka M., Nawrocki P., and Saah A.J. HIV-exposed twins. Lancet 339 (1992) 628
26. Bunders M., Thorne C., and Newell M.L. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 19 (2005) 1071-1079
27. Burns D.N., FitzGerald G., Semba R., Hershow R., Zorrilla C., Pitt J., Hammill H., Cooper E.R., Fowler M.G., and Landesman S. Vitamin A deficiency and other nutritional indices during pregnancy in human immunodeficiency virus infection: Prevalence, clinical correlates, and outcome. Women and Infants Transmission Study Group. Clin. Infect. Dis. 29 (1999) 328-334
28. Buseyne F., Scott-Algara D., Corre B., Porrot F., Monchatre E., Bellal N., Burgard M., Rouzioux C., Blanche S., and Riviere Y. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: Impact of age. Virology 354 (2006) 271-279
29. Calvelli T.A., and Rubinstein A. Pediatric HIV infection: A review. Immunodefic. Rev. 2 (1990) 83-127
30. Cao Y., Krogstad P., Korber B.T., Koup R.A., Muldoon M., Macken C., Song J.L., Jin Z., Zhao J.Q., Clapp S., Chen I.S., Ho D.D., et al. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nat. Med. 3 (1997) 549-552
31. Casper C., Naver L., Clevestig P., Belfrage E., Leitner T., Albert J., Lindgren S., Ottenblad C., Bohlin A.B., Fenyo E.M., and Ehrnst A. Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes. AIDS Res. Hum. Retroviruses 18 (2002) 343-352
32. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report (1992), Centers for Disease Control and Prevention
33. Chakraborty R. HIV-1 infection in children: A clinical and immunologic overview. Curr. HIV Res. 3 (2005) 31-41
34. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
35. Chandwani S., Greco M.A., Mittal K., Antoine C., Krasinski K., and Borkowsky W. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J. Infect. Dis. 163 (1991) 1134-1138
36. Cheng-Mayer C., Seto D., Tateno M., and Levy J.A. Biologic features of HIV-1 that correlate with virulence in the host. Science 240 (1988) 80-82
37. Cheng-Mayer C., Brown A., Harouse J., Luciw P.A., and Mayer A.J. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73 (1999) 5294-5300
38. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 (1996) 1135-1148
39. Chouquet C., Burgard M., Richardson S., Rouzioux C., and Costagliola D. Timing0020of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS 11 (1997) 1183-1184
40. Chung M.H., Kiarie J.N., Richardson B.A., Lehman D.A., Overbaugh J., and John-Stewart G.C. Breast milk HIV-1 suppression and decreased transmission: A randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. AIDS 19 (2005) 1415-1422
41. Cichutek K., Merget H., Norley S., Linde R., Kreuz W., Gahr M., and Kurth R. Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc. Natl. Acad. Sci. USA 89 (1992) 7365-7369
42. Clark D.R., Ampel N.M., Hallett C.A., Yedavalli V.R., Ahmad N., and DeLuca D. Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. J. Infect. Dis. 176 (1997) 649-654
43. Cochrane A.W., Perkins A., and Rosen C.A. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: Relevance of nucleolar localization to function. J. Virol. 64 (1990) 881-885
44. Connor R.I., and Ho D.D. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68 (1994) 4400-4408
45. Connor R.I., Chen B.K., Choe S., and Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206 (1995) 935-944
46. Contag C.H., Ehrnst A., Duda J., Bohlin A.B., Lindgren S., Learn G.H., and Mullins J.I. Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes. J. Virol. 71 (1997) 1292-1300
47. Cooper E.R., Nugent R.P., Diaz C., Pitt J., Hanson C., Kalish L.A., Mendez H., Zorrilla C., Hershow R., Moye J., Smeriglio V., and Fowler M.G. After AIDS clinical trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group. J. Infect. Dis. 174 (1996) 1207-1211
48. Daly T.J., Cook K.S., Gray G.S., Maione T.E., and Rusche J.R. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342 (1989) 816-819
49. Daly T.J., Rennert P., Lynch P., Barry J.K., Dundas M., Rusche J.R., Doten R.C., Auer M., and Farrington G.K. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element. Biochemistry 32 (1993) 8945-8954
50. Davison-Fairburn B., Baskin G., and Murphey-Corb M. Maternal-fetal transmission of SIV in 2 species of monkeys. In: Symposium Nonhuman Primate Models. AIDS 10 (1992) 29-35
51. De Rossi A., Ades A.E., Mammano F., Del Mistro A., Amadori A., Giaquinto C., and Chieco-Bianchi L. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS 5 (1991) 15-20
52. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 (1996) 1856-1862
53. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
54. Devash Y., Calvelli T.A., Wood D.G., Reagan K.J., and Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc. Natl. Acad. Sci. USA 87 (1990) 3445-3449
55. Di Marzio P., Choe S., Ebright M., Knoblauch R., and Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69 (1995) 7909-7916
56. di Marzo Veronese F., Copeland T.D., DeVico A.L., Rahman R., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231 (1986) 1289-1291
57. Dickover R.E., Garratty E.M., Herman S.A., Sim M.S., Plaeger S., Boyer P.J., Keller M., Deveikis A., Stiehm E.R., and Bryson Y.J. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 275 (1996) 599-605
58. Dickover R.E., Garratty E.M., Plaeger S., and Bryson Y.J. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J. Virol. 75 (2001) 2194-2203
59. Ding J., Jacobo-Molina A., Tantillo C., Lu X., Nanni R.G., and Arnold E. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer. J. Mol. Recognit. 7 (1994) 157-161
60. Ding J., Hughes S.H., and Arnold E. Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer. Biopolymers 44 (1997) 125-138
61. Douglas G.C., and King B.F. Maternal-fetal transmission of human immunodeficiency virus: A review of possible routes and cellular mechanisms of infection. Clin. Infect. Dis. 15 (1992) 678-691
62. Dunn D.T., Newell M.L., Ades A.E., and Peckham C.S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340 (1992) 585-588
63. Ehrnst A., Lindgren S., Dictor M., Johansson B., Sonnerborg A., Czajkowski J., Sundin G., and Bohlin A.B. HIV in pregnant women and their offspring: Evidence for late transmission. Lancet 338 (1991) 203-207
64. Epstein L.G., and Sharer L.R. Neurological manifestations of perinatally acquired HIV-1 infection. Semin. Pediatr. Neurol. 1 (1994) 50-57
65. Fackler O.T., d'Aloja P., Baur A.S., Federico M., and Peterlin B.M. Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity. J. Virol. 75 (2001) 6601-6608
66. Fang G., Burger H., Grimson R., Tropper P., Nachman S., Mayers D., Weislow O., Moore R., Reyelt C., Hutcheon N., Baker D., and Weiser B. Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission. Proc. Natl. Acad. Sci. USA 92 (1995) 12100-12104
67. Fazely F., Sharma P.L., Fratazzi C., Greene M.F., Wyand M.S., Memon M.A., Penninck D., and Ruprecht R.M. Simian immunodeficiency virus infection via amniotic fluid: A model to study fetal immunopathogenesis and prophylaxis. J. Acquir. Immune. Defic. Syndr. 6 (1993) 107-114
68. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
69. Feng Y.X., Campbell S., Harvin D., Ehresmann B., Ehresmann C., and Rein A. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: Possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J. Virol. 73 (1999) 4251-4256
70. Freed E.O. HIV-1 gag proteins: Diverse functions in the virus life cycle. Virology 251 (1998) 1-15
71. Frenkel L.M., Wagner II L.E., Demeter L.M., Dewhurst S., Coombs R.W., Murante B.L., and Reichman R.C. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin. Infect. Dis. 20 (1995) 1321-1326
72. Ganeshan S., Dickover R.E., Korber B.T., Bryson Y.J., and Wolinsky S.M. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71 (1997) 663-677
73. Garcia P.M., Kalish L.A., Pitt J., Minkoff H., Quinn T.C., Burchett S.K., Kornegay J., Jackson B., Moye J., Hanson C., Zorrilla C., and Lew J.F. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N. Engl. J. Med. 341 (1999) 394-402
74. Geels M.J., Cornelissen M., Schuitemaker H., Anderson K., Kwa D., Maas J., Dekker J.T., Baan E., Zorgdrager F., van den Burg R., van Beelen M., Lukashov V.V., et al. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J. Virol. 77 (2003) 12430-12440
75. Giaquinto C., Rampon O., and De Rossi A. Antiretroviral therapy for prevention of mother-to-child HIV transmission: Focus on single-dose nevirapine. Clin. Drug. Investig. 26 (2006) 611-627
76. Global summary of AIDS epidemic. UNAIDS/WHO AIDS epidemic update: December 2006 (2006). http://www.unaids.org/en/HIV_data/epi2006/
77. Goedert J.J., Duliege A.M., Amos C.I., Felton S., and Biggar R.J. High risk of HIV-1 infection for first-born twins. The international registry of HIV-exposed twins. Lancet 338 (1991) 1471-1475
78. Goh W.C., Rogel M.E., Kinsey C.M., Michael S.F., Fultz P.N., Nowak M.A., Hahn B.H., and Emerman M. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 4 (1998) 65-71
79. Gordon M., De Oliveira T., Bishop K., Coovadia H.M., Madurai L., Engelbrecht S., Janse van Rensburg E., Mosam A., Smith A., and Cassol S. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: Implications for vaccine and antiretroviral control strategies. J. Virol. 77 (2003) 2587-2599
80. Gotte M., Li X., and Wainberg M.A. HIV-1 reverse transcription: A brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch. Biochem. Biophys. 365 (1999) 199-210
81. Gotte M., Maier G., Gross H.J., and Heumann H. Localization of the active site of HIV-1 reverse transcriptase-associated RNase H domain on a DNA template using site-specific generated hydroxyl radicals. J. Biol. Chem. 273 (1998) 10139-10146
82. Goulder P.J., Brander C., Tang Y., Tremblay C., Colbert R.A., Addo M.M., Rosenberg E.S., Nguyen T., Allen R., Trocha A., Altfeld M., He S., et al. (2001). Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412 (2001) 334-338
83. Grody W.W., Fligiel S., and Naeim F. Thymus involution in the acquired immunodeficiency syndrome. Am. J. Clin. Pathol. 84 (1985) 85-95
84. Grzesiek S., Stahl S.J., Wingfield P.T., and Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35 (1996) 10256-10261
85. Guay L.A., Musoke P., Fleming T., Bagenda D., Allen M., Nakabiito C., Sherman J., Bakaki P., Ducar C., Deseyve M., Emel L., Mirochnick M., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354 (1999) 795-802
86. Hahn T., and Ahmad N. Genetic characterization of HIV type 1 gag p17 matrix genes in isolates from infected mothers lacking perinatal transmission. AIDS Res. Hum. Retroviruses 17 (2001) 1673-1680
87. Hahn T., Matala E., Chappey C., and Ahmad N. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission. AIDS Res. Hum. Retroviruses 15 (1999) 875-888
88. Hahn T., Ramakrishnan R., and Ahmad N. Evaluation of genetic diversity of human immunodeficiency virus type 1 NEF gene associated with vertical transmission. J. Biomed. Sci. 10 (2003) 436-450
89. Halsey N.A., Markham R., Wahren B., Boulos R., Rossi P., and Wigzell H. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. J. Acquir. Immune Defic. Syndr. 5 (1992) 153-157
90. Hammerschmid M., Palmeri D., Ruhl M., Jaksche H., Weichselbraun I., Bohnlein E., Malim M.H., and Hauber J. Scanning mutagenesis of the arginine-rich region of the human immunodeficiency virus type 1 Rev trans activator. J. Virol. 68 (1994) 7329-7335
91. Harris D., Kaushik N., Pandey P.K., Yadav P.N., and Pandey V.N. Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase. J. Biol. Chem. 273 (1998) 33624-33634
92. Heath M.J., Derebail S.S., Gorelick R.J., and DeStefano J.J. Differing roles of the N- and C-terminal zinc fingers in human immunodeficiency virus nucleocapsid protein-enhanced nucleic acid annealing. J. Biol. Chem. 278 (2003) 30755-30763
93. Henin Y., Mandelbrot L., Henrion R., Pradinaud R., Coulaud J.P., and Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J. Acquir. Immune Defic. Syndr. 6 (1993) 72-75
94. Henrard D.R., Phillips J.F., Muenz L.R., Blattner W.A., Wiesner D., Eyster M.E., and Goedert J.J. Natural history of HIV-1 cell-free viremia. JAMA 274 (1995) 554-558
95. Hira S.K., Kamanga J., Bhat G.J., Mwale C., Tembo G., Luo N., and Perine P.L. Perinatal transmission of HIV-I in Zambia. Br. Med. J. 299 (1989) 1250-1252
96. Hoff R., Berardi V.P., Weiblen B.J., Mahoney-Trout L., Mitchell M.L., and Grady G.F. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N. Engl. J. Med. 318 (1988) 525-530
97. Huang H., Chopra R., Verdine G.L., and Harrison S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science 282 (1998) 1669-1675
98. Husain M., Hahn T., Yedavalli V.R., and Ahmad N. Characterization of HIV type 1 tat sequences associated with perinatal transmission. AIDS Res. Hum. Retroviruses 17 (2001) 765-773
99. Hutto C., Zhou Y., He J., Geffin R., Hill M., Scott W., and Wood C. Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. J. Virol. 70 (1996) 3589-3598
100. Hwang S.S., Boyle T.J., Lyerly H.K., and Cullen B.R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253 (1991) 71-74
101. Iafrate A.J., Bronson S., and Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16 (1997) 673-684
102. Ibe S., Hotta N., Takeo U., Tawada Y., Mamiya N., Yamanaka K., Utsumi M., and Kaneda T. Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing. Microbiol. Immunol. 47 (2003) 499-505
103. Ibe S., Shibata N., Utsumi M., and Kaneda T. Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy. Microbiol. Immunol. 47 (2003) 71-79
104. Jacobo-Molina A., Ding J., Nanni R.G., Clark Jr. A.D., Lu X., Tantillo C., Williams R.L., Kamer G., Ferris A.L., Clark P., Hizi A., Hughes S., et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90 (1993) 6320-6324
105. Jain C., and Belasco J.G. Structural model for the cooperative assembly of HIV-1 Rev multimers on the RRE as deduced from analysis of assembly-defective mutants. Mol. Cell. 7 (2001) 603-614
106. Jameel S., Zafrullah M., Ahmad M., Kapoor G.S., and Sehgal S. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS 9 (1995) 685-690
107. Jeang K.T., Xiao H., and Rich E.A. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274 (1999) 28837-28840
108. John G.C., Rousseau C., Dong T., Rowland-Jones S., Nduati R., Mbori-Ngacha D., Rostron T., Kreiss J.K., Richardson B.A., and Overbaugh J. Maternal SDF1 3′A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission. J. Virol. 74 (2000) 5736-5739
109. Joshi V.V., and Oleske J.M. Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature. Arch. Pathol. Lab. Med. 109 (1985) 142-146
110. Julias J.G., McWilliams M.J., Sarafianos S.G., Arnold E., and Hughes S.H. Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo. Proc. Natl. Acad. Sci. USA 99 (2002) 9515-9520
111. Julias J.G., McWilliams M.J., Sarafianos S.G., Alvord W.G., Arnold E., and Hughes S.H. Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity. J. Virol. 77 (2003) 8548-8554
112. Kao S.M., Miller E.D., and Su L. A leucine zipper motif in the cytoplasmic domain of gp41 is required for HIV-1 replication and pathogenesisin vivo. Virology 289 (2001) 208-217
113. Kedar P.S., Arden K., Foyle M., Pope J.H., and Zeichner S.L. Umbilical cord blood mononuclear cell HIV-1 LTR Binding Activities. J. Biomed. Sci. 4 (1997) 217-228
114. Kimura T., Nishikawa M., and Ohyama A. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: Vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. J Biochem (Tokyo) 115 (1994) 1010-1020
115. Kitchen S.G., and Zack J.A. CXCR4 expression during lymphopoiesis: Implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 71 (1997) 6928-6934
116. Kliks S.C., Wara D.W., Landers D.V., and Levy J.A. Features of HIV-1 that could influence maternal-child transmission. JAMA 272 (1994) 467-474
117. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., and Steitz T.A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256 (1992) 1783-1790
118. Koito A., Harrowe G., Levy J.A., and Cheng-Mayer C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J. Virol. 68 (1994) 2253-2259
119. Korber B., Brander C., Haynes B.F., Koup R.A., Moore J., Walker B.D., and Watkins D.I. HIV Immunology and HIV/SIV Vaccine Databases (2003)
120. Koup R.A., and Wilson C.B. Clinical immunology of HIV-infected children. In: Pizzo P.A., and Wilfert C.M. (Eds). "Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents" (1993), Williams and Wilkins, Baltimore, Maryland 158-165
121. Kourtis A.P., Lee F.K., Abrams E.J., Jamieson D.J., and Bulterys M. Mother-to-child transmission of HIV-1: Timing and implications for prevention. Lancet. Infect. Dis. 6 (2006) 726-732
122. Koyanagi Y., Miles S., Mitsuyasu R.T., Merrill J.E., Vinters H.V., and Chen I.S. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236 (1987) 819-822
123. Krishnamoorthy G., Roques B., Darlix J.L., and Mely Y. DNA condensation by the nucleocapsid protein of HIV-1: A mechanism ensuring DNA protection. Nucleic Acids Res. 31 (2003) 5425-5432
124. Krivine A., Firtion G., Cao L., Francoual C., Henrion R., and Lebon P. HIV replication during the first weeks of life. Lancet 339 (1992) 1187-1189
125. Kuiken C., Foley B., Guzman E., Korber B., and Crandall K.A. The Evolution of HIV (1999), The John Hopinks University Press, Baltimore
126. Labrosse B., Labernardiere J.L., Dam E., Trouplin V., Skrabal K., Clavel F., and Mammano F. Baseline susceptibility of primary human immunodeficiency virus type 1 to entry inhibitors. J. Virol. 77 (2003) 1610-1613
127. Lairmore M.D., Cuthbert P.S., Utley L.L., Morgan C.J., Dezzutti C.S., Anderson C.L., and Sedmak D.D. Cellular localization of CD4 in the human placenta. Implications for maternal-to-fetal transmission of HIV. J. Immunol. 151 (1993) 1673-1681
128. Lamers S.L., Sleasman J.W., She J.X., Barrie K.A., Pomeroy S.M., Barrett D.J., and Goodenow M.M. Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J. Clin. Invest. 93 (1994) 380-390
129. Laure F., Courgnaud V., Rouzioux C., Blanche S., Veber F., Burgard M., Jacomet C., Griscelli C., and Brechot C. Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction. Lancet 2 (1988) 538-541
130. Lepage P., Van de Perre P., Carael M., Nsengumuremyi F., Nkurunziza J., Butzler J.P., and Sprecher S. Postnatal transmission of HIV from mother to child. Lancet 2 (1987) 400
131. Lohman B.L., Slyker J.A., Richardson B.A., Farquhar C., Mabuka J.M., Crudder C., Dong T., Obimbo E., Mbori-Ngacha D., Overbaugh J., Rowland-Jones S., and John-Stewart G. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J. Virol. 79 (2005) 8121-8130
132. Lu M., Stoller M.O., Wang S., Liu J., Fagan M.B., and Nunberg J.H. Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis. J. Virol. 75 (2001) 11146-11156
133. Lyman W.D., Kress Y., Rashbaum W.K., Calvelli T.A., Steinhauer E., Kashkin J.M., Henderson C.E., and Rubinstein A. An AIDS virus-associated antigen localized in human fetal brain. Ann. NY. Acad. Sci. 540 (1988) 628-629
134. Macreadie I.G., Castelli L.A., Hewish D.R., Kirkpatrick A., Ward A.C., and Azad A.A. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA 92 (1995) 2770-2774
135. Mahalingam S., Khan S.A., Jabbar M.A., Monken C.E., Collman R.G., and Srinivasan A. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology 207 (1995) 297-302
136. Mahalingam S., Ayyavoo V., Patel M., Kieber-Emmons T., and Weiner D.B. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71 (1997) 6339-6347
137. Malim M.H., Bohnlein S., Hauber J., and Cullen B.R. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell 58 (1989) 205-214
138. Malim M.H., McCarn D.F., Tiley L.S., and Cullen B.R. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65 (1991) 4248-4254
139. Mandal D., Jana S., Bhattacharya S.K., and Chakrabarti S. HIV type 1 subtypes circulating in eastern and northeastern regions of India. AIDS Res. Hum. Retroviruses 18 (2002) 1219-1227
140. Mangasarian A., Piguet V., Wang J.K., Chen Y.L., and Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 (1999) 1964-1973
141. Matala E., Crandall K.A., Baker R.C., and Ahmad N. Limited heterogeneity of HIV type 1 in infected mothers correlates with lack of vertical transmission. AIDS Res. Hum. Retroviruses 16 (2000) 1481-1489
142. Matala E., Hahn T., Yedavalli V.R., and Ahmad N. Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res. Hum. Retroviruses 17 (2001) 1725-1735
143. Matthews T.J., Langlois A.J., Robey W.G., Chang N.T., Gallo R.C., Fischinger P.J., and Bolognesi D.P. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83 (1986) 9709-9713
144. Maury W., Potts B.J., and Rabson A.B. HIV-1 infection of first-trimester and term human placental tissue: A possible mode of maternal-fetal transmission. J. Infect. Dis. 160 (1989) 583-588
145. MaWhinney S., Pagano M., and Thomas P. Age at AIDS diagnosis for children with perinatally acquired HIV. J. Acquir. Immune Defic. Syndr. 6 (1993) 1139-1144
146. Mayaux M.J., Blanche S., Rouzioux C., Le Chenadec J., Chambrin V., Firtion G., Allemon M.C., Vilmer E., Vigneron N.C., Tricoire J., Guillot F., Courpotin C., and French Pediatric HIV Infection Study Group. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8 (1995) 188-194
147. McClure H.M., Anderson D.C., Fultz P.N., Ansari A.A., Jehuda-Cohen T., Villinger F., Klumpp S.A., Switzer W., Lockwood E., Brodie A., et al. Maternal transmission of SIVsmm in rhesus macaques. J. Med. Primatol. 20 (1991) 182-187
148. McCormick-Davis C., Dalton S.B., Singh D.K., and Stephens E.B. Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates. AIDS Res. Hum. Retroviruses 16 (2000) 1089-1095
149. McGowan J.P., Crane M., Wiznia A.A., and Blum S. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women. Obstet. Gynecol. 94 (1999) 641-646
150. McNearney T., Westervelt P., Thielan B.J., Trowbridge D.B., Garcia J., Whittier R., and Ratner L. Limited sequence heterogeneity among biologically distinct human immunodeficiency virus type 1 isolates from individuals involved in a clustered infectious outbreak. Proc. Natl. Acad. Sci. USA 87 (1990) 1917-1921
151. Menendez-Arias L., Mas A., and Domingo E. Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review). Viral Immunol. 11 (1998) 167-181
152. Minkoff H., and Augenbraun M. Antiretroviral therapy for pregnant women. Am. J. Obstet. Gynecol. 176 (1997) 478-489
153. Miyauchi K., Komano J., Yokomaku Y., Sugiura W., Yamamoto N., and Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 79 (2005) 4720-4729
154. Mo H., Monard S., Pollack H., Ip J., Rochford G., Wu L., Hoxie J., Borkowsky W., Ho D.D., and Moore J.P. Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood. AIDS Res. Hum. Retroviruses 14 (1998) 607-617
155. Mok J.Q., Giaquinto C., De Rossi A., Grosch-Worner I., Ades A.E., and Peckham C.S. Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study. Lancet 1 (1987) 1164-1168
156. Moodley J., and Wennberg J.L. HIV in pregnancy. Curr. Opin. Obstet. Gynecol. 17 (2005) 117-121
157. Mulder-Kampinga G.A., Kuiken C., Dekker J., Scherpbier H.J., Boer K., and Goudsmit J. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. J. Gen. Virol. 74 Pt 9 (1993) 1747-1756
158. Mulder-Kampinga G.A., Simonon A., Kuiken C.L., Dekker J., Scherpbier H.J., van de Perre P., Boer K., and Goudsmit J. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J. Virol. 69 (1995) 2285-2296
159. Mulky A., Sarafianos S.G., Arnold E., Wu X., and Kappes J.C. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. J. Virol. 78 (2004) 7089-7096
160. Myers G., Korber B., and Hahn B.H. Human retroviruses and AIDS database (1995), Theoretical Biology, Los Alamos National Laboratory, Los Alamos
161. Nair P., Alger L., Hines S., Seiden S., Hebel R., and Johnson J.P. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J. Acquir. Immune Defic. Syndr. 6 (1993) 298-302
162. Narwa R., Roques P., Courpotin C., Parnet-Mathieu F., Boussin F., Roane A., Marce D., Lasfargues G., and Dormont D. Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission. J. Virol. 70 (1996) 4474-4483
163. Nduati R., John G., Mbori-Ngacha D., Richardson B., Overbaugh J., Mwatha A., Ndinya-Achola J., Bwayo J., Onyango F.E., Hughes J., and Kreiss J. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA 283 (2000) 1167-1174
164. Nduati R.W., John G.C., Richardson B.A., Overbaugh J., Welch M., Ndinya-Achola J., Moses S., Holmes K., Onyango F., and Kreiss J.K. Human immunodeficiency virus type 1-infected cells in breast milk: Association with immunosuppression and vitamin A deficiency. J. Infect. Dis. 172 (1995) 1461-1468
165. Newell M.L., and Peckham C. Risk factors for vertical transmission of HIV-1 and early markers of HIV-1 infection in children. AIDS 7 Suppl. 1 (1993) S91-S97
166. Nicholas S.W., Sondheimer D.L., Willoughby A.D., Yaffe S.J., and Katz S.L. Human immunodeficiency virus infection in childhood, adolescence, and pregnancy: A status report and national research agenda. Pediatrics 83 (1989) 293-308
167. Oberste M.S., and Gonda M.A. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6 (1992) 95-102
168. Oelrichs R.B., Shrestha I.L., Anderson D.A., and Deacon N.J. The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J. Virol. 74 (2000) 1149-1157
169. Ohagen A., Devitt A., Kunstman K.J., Gorry P.R., Rose P.P., Korber B., Taylor J., Levy R., Murphy R.L., Wolinsky S.M., and Gabuzda D. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J. Virol. 77 (2003) 12336-12345
170. Oleske J., Minnefor A., Cooper Jr. R., Thomas K., dela Cruz A., Ahdieh H., Guerrero I., Joshi V.V., and Desposito F. Immune deficiency syndrome in children. JAMA 249 (1983) 2345-2349
171. Olsen H.S., Beidas S., Dillon P., Rosen C.A., and Cochrane A.W. Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element. J. Acquir. Immune Defic. Syndr. 4 (1991) 558-567
172. Parekh B.S., Shaffer N., Pau C.P., Abrams E., Thomas P., Pollack H., Bamji M., Kaul A., Schochetman G., Rogers M., George J.R., NYC, and Collaborative Group. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. AIDS 5 (1991) 1179-1184
173. Pasquier C., Cayrou C., Blancher A., Tourne-Petheil C., Berrebi A., Tricoire J., Puel J., and Izopet J. Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1. J. Virol. 72 (1998) 8493-8501
174. Peters S., Munoz M., Yerly S., Sanchez-Merino V., Lopez-Galindez C., Perrin L., Larder B., Cmarko D., Fakan S., Meylan P., and Telenti A. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J. Virol. 75 (2001) 9644-9653
175. Petropoulou H., Stratigos A.J., and Katsambas A.D. Human immunodeficiency virus infection and pregnancy. Clin. Dermatol. 24 (2006) 536-542
176. Philpott S., Burger H., Charbonneau T., Grimson R., Vermund S.H., Visosky A., Nachman S., Kovacs A., Tropper P., Frey H., and Weiser B. CCR5 genotype and resistance to vertical transmission of HIV-1. J. Acquir. Immune Defic. Syndr. 21 (1999) 189-193
177. Poon D.T., Wu J., and Aldovini A. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70 (1996) 6607-6616
178. Price D.A., Goulder P.J., Klenerman P., Sewell A.K., Easterbrook P.J., Troop M., Bangham C.R., and Phillips R.E. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94 (1997) 1890-1895
179. Putney S.D., Matthews T.J., Robey W.G., Lynn D.L., Robert-Guroff M., Mueller W.T., Langlois A.J., Ghrayeb J., Petteway Jr. S.R., Weinhold K.J., Fischinger P.J., WongStaal F., et al. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234 (1986) 1392-1395
180. Ramakrishnan R., Hussain M., Holzer A., Mehta R., Sundaravaradan V., and Ahmad N. Evaluations of HIV type 1 rev gene diversity and functional domains following perinatal transmission. AIDS Res. Hum. Retroviruses 21 (2005) 1035-1045
181. Ramakrishnan R., Mehta R., Sundaravaradan V., Davis T., and Ahmad N. Characterization of HIV-1 envelope gp41 genetic diversity and functional domains following perinatal transmission. Retrovirology 3 (2006) 42
182. Rana T.M., and Jeang K.T. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch. Biochem. Biophys. 365 (1999) 175-185
183. Reeves J.D., Gallo S.A., Ahmad N., Miamidian J.L., Harvey P.E., Sharron M., Pohlmann S., Sfakianos J.N., Derdeyn C.A., Blumenthal R., Hunter E., and Doms R.W. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proc. Natl. Acad. Sci. USA 99 (2002) 16249-16254
184. Reitter J.N., Means R.E., and Desrosiers R.C. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4 (1998) 679-684
185. Report of a Consensus Workshop. Report of a Consensus Workshop, Siena, Italy, January 17-18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1. J. Acquir. Immune Defic. Syndr. 5 (1992) 1019-1029
186. Resino S., Gurbindo D., Cano J.M., Sanchez-Ramon S., and Muoz-Fernandez M.A. Predictive markers of clinical outcome in vertically HIV-1-infected infants. A prospective longitudinal study. Pediatr. Res. 47 (2000) 509-515
187. Richman D.D., and Bozzette S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169 (1994) 968-974
188. Rogers M.F., Ou C.Y., Rayfield M., Thomas P.A., Schoenbaum E.E., Abrams E., Krasinski K., Selwyn P.A., Moore J., Kaul A., et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N. Engl. J. Med. 320 (1989) 1649-1654
189. Rogers M.F., Thomas P.A., Starcher E.T., Noa M.C., Bush T.J., and Jaffe H.W. Acquired immunodeficiency syndrome in children: Report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics 79 (1987) 1008-1014
190. Rosenzweig M., Clark D.P., and Gaulton G.N. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 7 (1993) 1601-1605
191. Rossi P., Moschese V., Broliden P.A., Fundaro C., Quinti I., Plebani A., Giaquinto C., Tovo P.A., Ljunggren K., Rosen J., Wigzell H., Jondal M., et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc. Natl. Acad. Sci. USA 86 (1989) 8055-8058
192. Rousseau C.M., Nduati R.W., Richardson B.A., John-Stewart G.C., Mbori-Ngacha D.A., Kreiss J.K., and Overbaugh J. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J. Infect. Dis. 190 (2004) 1880-1888
193. Rouzioux C., Costagliola D., Burgard M., Blanche S., Mayaux M.J., Griscelli C., and Valleron A.J. Timing of mother-to-child HIV-1 transmission depends on maternal status. The HIV Infection in Newborns French Collaborative Study Group. AIDS 7 Suppl. 2 (1993) S49-S52
194. Rowland-Jones S.L., Phillips R.E., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., Elvin J.G., Rothbard J.A., Bangham C.R., Rizza C.R., et al. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. AIDS Res. Hum. Retroviruses 8 (1992) 1353-1354
195. Rubinstein A., Sicklick M., Gupta A., Bernstein L., Klein N., Rubinstein E., Spigland I., Fruchter L., Litman N., Lee H., and Hollander M. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA 249 (1983) 2350-2356
196. Rusche J.R., Javaherian K., McDanal C., Petro J., Lynn D.L., Grimaila R., Langlois A., Gallo R.C., Arthur L.O., Fischinger P.J., Bolognesi D.P., Putney S.D., et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad. Sci. USA 85 (1988) 3198-3202
197. Ryder R.W., Nsa W., Hassig S.E., Behets F., Rayfield M., Ekungola B., Nelson A.M., Mulenda U., Francis H., Mwandagalirwa K., Davachi F., Rogers M., et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N. Engl. J. Med. 320 (1989) 1637-1642
198. Saksela K., Cheng G., and Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14 (1995) 484-491
199. Sato H., Shiino T., Kodaka N., Taniguchi K., Tomita Y., Kato K., Miyakuni T., and Takebe Y. Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family. J. Virol. 73 (1999) 3551-3559
200. Scarlatti G., Albert J., Rossi P., Hodara V., Biraghi P., Muggiasca L., and Fenyo E.M. Mother-to-child transmission of human immunodeficiency virus type 1: Correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168 (1993) 207-210
201. Scarlatti G., Leitner T., Halapi E., Wahlberg J., Marchisio P., Clerici-Schoeller M.A., Wigzell H., Fenyo E.M., Albert J., Uhlen M., and Rossi P. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc. Natl. Acad. Sci. USA 90 (1993) 1721-1725
202. Schnittman S.M., Denning S.M., Greenhouse J.J., Justement J.S., Baseler M., Kurtzberg J., Haynes B.F., and Fauci A.S. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta+ and TCR gamma delta+ to human immunodeficiency virus infection: A mechanism for CD4+ (T4) lymphocyte depletion. Proc. Natl. Acad. Sci. USA 87 (1990) 7727-7731
203. Schubert U., and Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68 (1994) 2260-2271
204. Schubert U., Clouse K.A., and Strebel K. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69 (1995) 7699-7711
205. Schwartz D.A., and Nahmias A.J. Human immunodeficiency virus and the placenta. Current concepts of vertical transmission in relation to other viral agents. Ann. Clin. Lab. Sci. 21 (1991) 264-274
206. Scott G.B., Buck B.E., Leterman J.G., Bloom F.L., and Parks W.P. Acquired immunodeficiency syndrome in infants. N. Engl. J. Med. 310 (1984) 76-81
207. Scott G.B., Fischl M.A., Klimas N., Fletcher M.A., Dickinson G.M., Levine R.S., and Parks W.P. Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers. JAMA 253 (1985) 363-366
208. Scott R. Danforths Obstetrics and Gynecology. 7th edn (1994), JB Lippincott, Philadelphia, Pennsylvania
209. Selby M.J., and Peterlin B.M. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62 (1990) 769-776
210. Semba R.D. Overview of the potential role of vitamin A in mother-to-child transmission of HIV-1. Acta Paediatr. Suppl. 421 (1997) 107-112
211. Semba R.D., Kumwenda N., Hoover D.R., Taha T.E., Quinn T.C., Mtimavalye L., Biggar R.J., Broadhead R., Miotti P.G., Sokoll L.J., van der Hoeven L., and Chiphangwi J.D. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis. 180 (1999) 93-98
212. Shaffer N., Chuachoowong R., Mock P.A., Bhadrakom C., Siriwasin W., Young N.L., Chotpitayasunondh T., Chearskul S., Roongpisuthipong A., Chinayon P., Karon J., Mastro T.D., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353 (1999) 773-780
213. Shioda T., Levy J.A., and Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349 (1991) 167-169
214. Sleasman J.W., Aleixo L.F., Morton A., Skoda-Smith S., and Goodenow M.M. CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children. AIDS 10 (1996) 1477-1484
215. Sova P., van Ranst M., Gupta P., Balachandran R., Chao W., Itescu S., McKinley G., and Volsky D.J. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J. Virol. 69 (1995) 2557-2564
216. Sprecher S., Soumenkoff G., Puissant F., and Degueldre M. Vertical transmission of HIV in 15-week fetus. Lancet 2 (1986) 288-289
217. Stamatatos L., and Cheng-Mayer C. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67 (1993) 5635-5639
218. Stanley S.K., McCune J.M., Kaneshima H., Justement J.S., Sullivan M., Boone E., Baseler M., Adelsberger J., Bonyhadi M., Orenstein J., Fox C.H., and Fauci A.S. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178 (1993) 1151-1163
219. Strebel K., Klimkait T., Maldarelli F., and Martin M.A. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63 (1989) 3784-3791
220. Strunnikova N., Ray S.C., Livingston R.A., Rubalcaba E., and Viscidi R.P. Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. J. Virol. 69 (1995) 7548-7558
221. Sundaravaradan V., Hahn T., and Ahmad N. Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmission. Retrovirology 2 (2005) 36
222. Sundaravaradan V., Saxena S.K., Ramakrishnan R., Yedavalli V.R., Harris D.T., and Ahmad N. Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression. Proc. Natl. Acad. Sci. USA 103 (2006) 11701-11706
223. Tencza S.B., Miller M.A., Islam K., Mietzner T.A., and Montelaro R.C. Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein. J. Virol. 69 (1995) 5199-5202
224. Tersmette M., de Goede R.E., Al B.J., Winkel I.N., Gruters R.A., Cuypers H.T., Huisman H.G., and Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62 (1988) 2026-2032
225. Terwilliger E.F., Cohen E.A., Lu Y.C., Sodroski J.G., and Haseltine W.A. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA 86 (1989) 5163-5167
226. The European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study. Lancet 343 (1994) 1464-1467
227. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial. The European Mode of Delivery Collaboration. Lancet 353 (1999) 1035-1039
228. Thomas S.L., Oft M., Jaksche H., Casari G., Heger P., Dobrovnik M., Bevec D., and Hauber J. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. J. Virol. 72 (1998) 2935-2944
229. Tiemessen C.T., and Kuhn L. Immune pathogenesis of pediatric HIV-1 infection. Curr. HIV/AIDS Rep. 3 (2006) 13-19
230. Tiganos E., Friborg J., Allain B., Daniel N.G., Yao X.J., and Cohen E.A. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein. Virology 251 (1998) 96-107
231. Toohey K., Wehrly K., Nishio J., Perryman S., and Chesebro B. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213 (1995) 70-79
232. Tovo P.A., de Martino M., Gabiano C., Cappello N., D'Elia R., Loy A., Plebani A., Zuccotti G.V., Dallacasa P., Ferraris G., Palomba E., and Ruga E. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet 339 (1992) 1249-1253
233. Ullum H., Lepri A.C., Victor J., Skinhoj P., Phillips A.N., and Pedersen B.K. Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: Evidence from a cohort of 347 HIV-infected individuals. AIDS 11 (1997) 1479-1485
234. van Dyke R.B. Opportunistic infections in pediatric HIV disease. In: Lyman W.D., and Rubinstein A. (Eds). "Pediatric AIDS: Clinical, Pathologic and Basic Science Perspectives" (1993), New York Academy of Sciences, New York, New York 129-157
235. Van't Wout A.B., Kootstra N.A., Mulder-Kampinga G.A., Albrecht-van Lent N., Scherpbier H.J., Veenstra J., Boer K., Coutinho R.A., Miedema F., and Schuitemaker H. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94 (1994) 2060-2067
236. Viscarello R.R., Cullen M.T., DeGennaro N.J., and Hobbins J.C. Fetal blood sampling in human immunodeficiency virus-seropositive women before elective midtrimester termination of pregnancy. Am. J. Obstet. Gynecol. 167 (1992) 1075-1079
237. Watts N.R., Misra M., Wingfield P.T., Stahl S.J., Cheng N., Trus B.L., Steven A.C., and Williams R.W. Three-dimensional structure of HIV-1 Rev protein filaments. J. Struct. Biol. 121 (1998) 41-52
238. Weiblen B.J., Lee F.K., Cooper E.R., Landesman S.H., McIntosh K., Harris J.A., Nesheim S., Mendez H., Pelton S.I., Nahmias A.J., and Hoff R. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet 335 (1990) 988-990
239. Weinbreck P., Loustand V., and Denis F. Postnatal transmission of HIV infection. Lancet 1 (1988) 482
240. Weiss R. Cellular receptors and viral glycoproteins involved in retrovirus entry. In: Levy J.A. (Ed). "The Retroviridae" (1993), Plenum Press, New York 1-108
241. Welker R., Harris M., Cardel B., and Krausslich H.G. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: Analysis of its role in enhancement of viral infectivity. J. Virol. 72 (1998) 8833-8840
242. Wellensiek B.P., Sundaravaradan V., Ramakrishnan R., and Ahmad N. Molecular characterization of the HIV-1 gag nucleocapsid gene associated with vertical transmission. Retrovirology 3 (2006) 21
243. Westervelt P., Trowbridge D.B., Epstein L.G., Blumberg B.M., Li Y., Hahn B.H., Shaw G.M., Price R.W., and Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66 (1992) 2577-2582
244. Wiktor S.Z., Ekpini E., Karon J.M., Nkengasong J., Maurice C., Severin S.T., Roels T.H., Kouassi M.K., Lackritz E.M., Coulibaly I.M., and Greenberg A.E. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial. Lancet 353 (1999) 781-785
245. Willey R.L., Theodore T.S., and Martin M.A. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68 (1994) 4409-4419
246. Willey R.L., Smith D.H., Lasky L.A., Theodore T.S., Earl P.L., Moss B., Capon D.J., and Martin M.A. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62 (1988) 139-147
247. Wilson C.C., Brown R.C., Korber B.T., Wilkes B.M., Ruhl D.J., Sakamoto D., Kunstman K., Luzuriaga K., Hanson I.C., Widmayer S.M., Wiznia A., Clapp S., et al. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: The ariel project for the prevention of transmission of HIV from mother to infant. J. Virol. 73 (1999) 3975-3985
248. Wolinsky S.M., Wike C.M., Korber B.T., Hutto C., Parks W.P., Rosenblum L.L., Kunstman K.J., Furtado M.R., and Munoz J.L. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255 (1992) 1134-1137
249. Wu X., Parast A.B., Richardson B.A., Nduati R., John-Stewart G., Mbori-Ngacha D., Rainwater S.M., and Overbaugh J. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J. Virol. 80 (2006) 835-844
250. Yang X., Goncalves J., and Gabuzda D. Phosphorylation of Vif and its role in HIV-1 replication. J. Biol. Chem. 271 (1996) 10121-10129
251. Yao X.J., Friborg J., Checroune F., Gratton S., Boisvert F., Sekaly R.P., and Cohen E.A. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: A predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209 (1995) 615-623
252. Yedavalli V.R., and Ahmad N. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission. AIDS Res. Hum. Retroviruses 17 (2001) 911-923
253. Yedavalli V.R., Chappey C., and Ahmad N. Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission. J. Virol. 72 (1998) 6937-6943
254. Yedavalli V.R., Chappey C., Matala E., and Ahmad N. Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission. J. Virol. 72 (1998) 1092-1102
255. Yedavalli V.R., Husain M., Horodner A., and Ahmad N. Molecular characterization of HIV type 1 vpu genes from mothers and infants after perinatal transmission. AIDS Res. Hum. Retroviruses 17 (2001) 1089-1098
256. Zaitseva M.B., Lee S., Rabin R.L., Tiffany H.L., Farber J.M., Peden K.W., Murphy P.M., and Golding H. CXCR4 and CCR5 on human thymocytes: Biological function and role in HIV-1 infection. J. Immunol. 161 (1998) 3103-3113
257. Zapp M.L., Hope T.J., Parslow T.G., and Green M.R. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: A dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. USA 88 (1991) 7734-7738
258. Zhang H., Hoffmann F., He J., He X., Kankasa C., West J.T., Mitchell C.D., Ruprecht R.M., Orti G., and Wood C. Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease. Retrovirology 3 (2006) 73
259. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., and Ho D.D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 (1993) 1179-1181
260. Ziegler J.B., Cooper D.A., Johnson R.O., and Gold J. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1 (1985) 896-898
261. Zuber G., McDermott J., Karanjia S., Zhao W., Schmid M.F., and Barklis E. Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA. J. Virol. 74 (2000) 7431-7441